CRISPR Therapeutics
CRSP
CRSP
64 hedge funds and large institutions have $180M invested in CRISPR Therapeutics in 2017 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
64
Holders Change
+25
Holders Change %
+64.1%
% of All Funds
1.6%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.15%
New
28
Increased
14
Reduced
6
Closed
3
Calls
$27K
Puts
$983K
Net Calls
-$956K
Net Calls Change
-$635K